We sought a model to estimate preanalytical uncertainty of blood samples collected and processed by using optimal procedures.
Preanalytical uncertainty is attributable to variations in blood sample collection and sample handling that occur before the blood sample is analyzed (1 ) . In the preanalytical phase of clinical chemistry analyses many sources may contribute to erroneous results (2 ) . Preanalytical errors, such as missing identification of the patient, use of the wrong blood tubes, and ordering of the wrong tests, should not be confused with the quantifiable preanalytical uncertainty that is due to variation in current laboratory practice such as the use of different blood tubes, variation in clotting time (precentrifugation phase), and variation in centrifugal force and storage time (3 ) .
The use of variable preanalytical routines in current practice may increase uncertainty and lead to a bias in the results (3 ) and possible alterations in interpretation of the test. In some cases the preanalytical uncertainty may be the dominant variability.
The Guide to Expression of Uncertainty in Measurement (GUM) 4 establishes general rules for expressing uncertainty in measurement (4 ), including those for converting the uncertainty estimates into standard form, combining them, and calculating the combined uncertainty.
In some preanalytical studies, ANOVA and BlandAltman plots have been used to compare an ideal preanalytical situation to an alternative situation (5) (6) (7) (8) . In other studies (9 -11 ) the preanalytical uncertainty has been estimated according to a specific practice, without addressing the effect expected for an optimal preanalytical practice.
We have previously presented a model for constructing a preanalytical uncertainty budget for clinical chemistry analyses (3 ) . In this model, the effects of various alternative preanalytical practices were estimated, compared to an optimal practice for handling the blood samples. However, the model did not determine the uncertainty in the optimal practice itself.
The aim of our current study was to estimate the preanalytical uncertainty when the phlebotomy and the sample handling are performed optimally according to existing standards (12, 13 ) . This minimal preanalytical uncertainty will influence all patient results, and may be used as a standard of reference for evaluation of preanalytical uncertainty in current practice.
To estimate the uncertainty caused by the phlebotomy procedure itself, we performed venipuncture on both arms of each participant. Collection of blood samples into 2 different types of blood tubes enabled us to detect any differences in preanalytical variation. Linear mixed-effects models (14 ) were used to estimate the between-venipuncture variation, and the preanalytical variation (except for between-venipuncture variation), together with any fixed effects, and the measurement repeatability for 15 clinical chemistry analytes.
Materials and Methods

SAMPLE HANDLING AND ANALYSIS
After we obtained approval for the study from the local ethics committee and informed and written confirmation from study participants in accordance with the Helsinki Declaration, we performed phlebotomy on 20 nonfasting volunteers from our laboratory in accordance with a standardized procedure (13 ) .
To minimize trauma to erythrocytes, we used wide-bore (21-gauge, Becton Dickson) needles for venipunctures. All phlebotomy was performed between 9 and 10 AM by the same medical technician, with each participant in a sitting position for approximately 10 min at ambient temperature. The tourniquet was loosely fastened and released after Ͻ1 min, immediately when blood appeared. Repeated clenching and unclenching of the fist was not allowed. The blood samples were collected into plastic serum-separation Vacutainer (Becton Dickson) gel tubes: serum-separation tubes (SST)-II advance tubes 3.5 mL containing silica clot activator and rapidserum tubes (RST) 4.0 mL containing a thrombin-based medical clotting agent.
Two tubes of each type were collected in random order from each arm, i.e., 4 tubes from each arm, for a total of 8 tubes from each person. The tubes were completely filled, mixed gently by 5 inversions, and put in a vertical position. The mean venipuncture duration for both arms was 3 min (range 2-7 min). The right arm was always phlebotomized first, and therefore the clotting time was always about 1-2 min longer for the tubes collected from the right arm. The clotting time was standardized according to the manufacturer's recommendation; for the RST tubes it varied from 5 to 8 min, and for the SSTs from 30 to 33 min. As recommended by the manufacturer, the tubes were centrifuged for 10 min at 1600g in a swing-out centrifuge (Kubota 5930, Kubota Corporation) at 20°C.
Immediately after centrifugation, the serum from each gel tube was separated into 2 secondary tubes. Thus the tubes from each person were analyzed in duplicate, randomly under repeatability (within-run) conditions, on Roche Modular Analytics SWA (serum work area) instruments by photometric methods (Roche Diagnostics).
Albumin was measured with the bromcresol green method; alkaline phosphatase (ALP) liquid according to IFCC; alanine aminotransferase (ALT) according to IFCC with pyridoxal phosphate activation; calcium with o-cresolphthalein; creatine kinase (CK) liquid according to IFCC; creatinine with creatinine plus; ␥-glutamyltransferase (GGT) liquid according to IFCC; glucose with Gluco-quant Glucose/HK; HDLcholesterol (HDL-C) with HDLC3 (HDL-C plus 3rd generation), no pretreatment; lactate dehydrogenase liquid (LDH) according to IFCC; magnesium with xylidyl blue; potassium and sodium with ISE (ion-selective electrode) indirect; total cholesterol (TC) with CHOD-PAP (cholesterol oxidase phenol 4-aminophenazone peroxidase); and triglycerides (TG) with GPO-PAP (glycerol phosphate oxidase 4-aminophenazone). A photometric method, the hemoglobin index (H-index), was used for measuring hemolysis; 100 H-index units correspond to approximately 0.06 mmol/L (0.1 g/dL) of hemoglobin. The samples from the RSTs were analyzed on average 33 min (range 21-62 min) after phlebotomy and from the SSTs on average 61 min (range 46 -95 min) after phlebotomy.
STATISTICAL ANALYSIS
Data were analyzed by use of linear mixed-effects models (14 ) . Mixed-effects models allow clustered multilevel data and also allow separate estimates of fixed effects and random effects. Fixed effects represent systematic differences due to covariates e.g., between arms, and SST vs RST tubes, similarly to regression models for unclustered data. Random effects were expressed as SDs for random variation between groups at each level, e.g., between persons, arm from which sample was collected, tubes from each arm, and, finally, duplicates from each tube, representing measurement repeatability. We used the package Linear and Nonlinear Mixed Effects Models in R (The R Foundation for Statistical Comput-ing) for the mixed effects analyses (15 ) . The level for statistical significance was set to 0.05.
We calculated 95% CIs for both the fixed and random effects. Comparisons of the SDs were performed by evaluation of the overlap of their CIs, and the SDs were considered significantly different when their CIs did not overlap.
In accordance with the GUM model, the SDs were combined by squaring, adding, and calculating the square root of the added variances (4 ).
Results
No significant systematic differences were found between results from successive venipunctures in both arms for any of the analytes (Table 1) .
There was, however, a significant mean difference (P Ͻ 0.05, Table 1 ) between the SST tubes related to the RST tubes for albumin, calcium, glucose, LDH, magnesium, potassium, and TC. The H-index for the SST tubes was significantly higher than the RST tubes (Table 1), with mean 5.15 (range 0 -16) and mean 3.63 (range 0 -8), respectively.
The preanalytical SDs (excluding venipuncture) estimated separately for use of the RST tubes and the SST tubes were not found to be significantly different from each other (Table 2) . Therefore, the results from both the tubes were included in the subsequent calculations of random variation. Table 3 displays for each analyte the mean and the concentration range of the samples, the SDs (95% CI) and relative SDs (CV%) for the between-venipuncture variation, the preanalytical variation (excluding venipuncture), and the measurement repeatability. The combined SDs in column 6 include the betweenvenipuncture SDs and the preanalytical SDs (excluding venipuncture), whereas in column 7 the combined SDs also include the measurement repeatability SDs. The contribution of variance from each source to the total variance is presented in Fig. 1 .
The preanalytical SDs (excluding venipuncture) for LDH (3.2 U/L, 95% CI 2.8 -3.7) and potassium (0.092 mmol/L, 95% CI 0.080 -0.11) were significantly higher than the measurement repeatability SDs (1.9 U/L, 95% CI 1.7-2.1) and (0.031 mmol/L, 95% CI 0.028 -0.035), respectively ( Table 3 ). The measurement repeatability SD was significantly higher than the preanalytical SD (excluding venipuncture) for GGT and magnesium, and significantly higher than the between-venipuncture SD for ALT and magnesium. For glucose the between-venipuncture SD was 0.20 mmol/L (95% CI 0.14 -0.27), which was significantly higher than the preanalytical SD (excluding venipuncture) (0.07 mmol/L, 95% CI 0.06 -0.08) and the measurement-repeatability SD (0.057 mmol/L, 95% CI 0.051-0.064). The between-venipuncture SD was also significantly higher than the measurement repeatability SD for ALP and potassium. For albumin, calcium, CK, creatinine, HDL-C, TC, and TG the betweenvenipuncture, preanalytical (excluding venipuncture) and measurement-repeatability SDs were of similar magnitude, and generally demonstrated overlapping CIs. The between-venipuncture SD for sodium resulted in a wide 95% CI; owing to this statistical instability, and as recommended elsewhere (14 ) , the model was simplified by combining the betweenvenipuncture and preanalytical (excluding venipuncture) random effects to a common estimate SD 0.26 (95% CI 0.14 -0.47) mmol/L ( Table 3 ). The CI for preanalytical SD (excluding venipuncture) showed instability for GGT measured in SST tubes, magnesium measured in RST tubes, and sodium measured in both RST and in SST tubes (Table 2) . Sensitivity analysis was done by excluding possible outliers, 1 outlier each for ALT, magnesium, and TC. Because the outliers had no influence on the estimated SDs (Table 3) or on the differences displayed in Table 1 , they were not excluded in the main analysis.
Discussion
To reduce random preanalytical variation it is vital to identify the contributions of the various uncertainty sources, from venipuncture to analysis. Linear mixedeffects models (14 ) constitute a well-developed and suitable method to identify different sources of variation, and fixed effects in a data set when both effects may be present.
The procedures applied for optimal collection and handling of the blood samples before analysis are based on guidelines (12, 13 ) . Complete clotting normally occurs within 30 -60 min at room temperature, but it could be accelerated to 5 min with the use of blood tubes containing thrombin (12 ) , such as the RST tubes used in this study. For centrifuge time and relative centrifugal force the tube manufacturer's recommendations should be consulted (12 ) . Serum should be separated from the erythrocytes as soon as possible, or within a maximum limit of 2 h after the phlebotomy (12 ) . Temperature and time of storage may influence the stability of biochemical components in serum (12 ) .
The uncertainty chain starts with the choice of blood-collection tube. We found a fixed effect representing a significant, systematic difference in the results from the SST vs the RST tubes for some analytes (Table  1) . This difference may be due to the SSTs having longer clotting time, the RST tubes being analyzed about 30 min sooner than the SSTs, and the fact that the tubes have different clotting agents. The estimated mean difference between the SST and the RST tubes for glucose (Ϫ0.16 mmol/L, 95% CI Ϫ0.18 to Ϫ0.13) was significant, meaning that the choice of correct tubes is important to minimize the preanalytical uncertainty, even when following an optimal protocol. Our first study (3 ) showed that measured glucose concentrations were significantly decreased by prolonged clotting time. Because of glycolysis the concentration of glucose decreases with prolonged contact with the clot (1 ).
The H-index was significantly higher in the SST tubes, and this result may explain the significant difference between the tubes for potassium, LDH, and magnesium, with the SSTs showing higher concentration.
It might be expected that the preanalytical variation (excluding venipuncture) may be different for the different tube types because of different clotting times. The combined SDs in column 7 include the between-venipuncture, the preanalytical (excluding between-venipuncture) and the measurement repeatability SDs. c Line 1, SD (95% CI). d Line 2, CV%. e Because of a wide 95% CI for the between-venipuncture SD, the venipuncture and preanalytical SD (excluding between-venipuncture) was combined to a common estimate.
However, the preanalytical SDs (excluding venipuncture) estimated for each tube type were not found to be significantly different (Table 2 ). Therefore the data from both tubes were used in the main analyses (Tables  1 and 3 , and Fig. 1 ). Because samples were collected by phlebotomy performed in both arms of the sample donors, we included a fixed effect representing the arm used (left or right), and a random effect between the venipunctures. We found no significant bias between arms (Table 1) , but a considerable between-venipuncture variation (Table 3) . A reported study on the effect of specimen collection on coagulation assays (7 ) also revealed no significant difference between the results from phlebotomy in the left vs right arm.
The between-venipuncture SD may be a result of variation in blood flow, muscle strength, blood pressure, and other biochemical or physiological effects. Small differences in the position of the arm, the strength of the tourniquet, and the cut, depth, and duration of the venipunctures may all contribute to the uncertainty of the venipuncture. In sum, the betweenvenipuncture variation turned out to be somewhat higher than the preanalytical variation (excluding venipuncture) for several analytes, and for glucose in particular it was the dominant source of variation. For ALP and potassium the between-venipuncture SD was significantly higher than the measurement repeatability.
Results of a study on the influence of needle-bore size showed that using small needles could lead to higher variability of potassium results (8 ) . A study of the influence of tourniquet application on venous blood sampling for serum chemistry showed that serum electrolytes are not affected by stasis up to 180 s (5 ). However, Lippi et al. concluded that albumin, calcium, and potassium showed clinically significant differences after as little as 1 min of stasis, and several other analytes after 3 min of stasis (16 ) .
The preanalytical SD (excluding venipuncture) is a result of variations in variables that include filling volume, sample mixing, clotting time, extent of hemolysis, centrifugal force, room temperature and humidity, and amount of time before analysis. Even with optimal routine, some variation is inevitable.
For LDH and potassium the preanalytical SD (excluding venipuncture) was significantly higher than the measurement-repeatability SD. It is well known that LDH and potassium are particularly sensitive to hemolysis (1 ) , and there may be some leakage out of the cell even without visible hemolysis. These analytes are therefore particularly important to standardize. Hemolysis has been suggested to be a suitable indicator for preanalytical quality (17 ) and is a leading cause of unsuitable specimens in clinical laboratories (18 ) . In the study by Fuentes-Arderiu et al. (9 ) the preanalytical uncertainty (including venipuncture) for glucose was estimated to be 3.2%, and for potassium to be 3.1%. Kouri et al. (19 ) estimated the preanalytical uncertainty to be 6.6% for potassium, 0.7% for TC, and 4.7% for albumin, by adding uncertainties from, e.g., specimen collection and delay in pretreatment and transportation.
The estimated measurement repeatability SDs (Table 3) were in agreement with the measurement repeatability SDs calculated from control material used in our clinical routine. Although the measurement repeatability SD is the smallest achievable measurement variation, it was the dominant source of variation for ALT, GGT, and magnesium. Linear mixed-effects models are powerful tools for quantifying variance from a variety of sources. With appropriate experimental designs, this approach can be used for the evaluation of interindividual, preanalytical, and analytical sources. Both random and fixed preanalytical effects can be determined and combined with measurement variation to give the total uncertainty of laboratory results. Empirical Bayesian models also could be used as an alternative statistical method to linear mixed-effects models (14 ) .
By use of samples collected under optimal conditions, we have estimated the minimal preanalytical uncertainty. This minimal uncertainty will influence all patient results, and may be compared with preanalytical uncertainty in current practice. For many of the analytes tested, the contribution of venipuncture to the total uncertainty was considerable. The method we used is practical and can easily be adopted by routine laboratories. 
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